News: Portfolio 2008

TETRALOGIC PHARMACEUTICALS APPOINTS DR. ANDREW PECORA AS CHAIRMAN OF THE BOARD

Malvern, PA – May 6, 2008 - TetraLogic Pharmaceuticals, a privately held biopharmaceutical company announced today the appointment of Dr. Andrew Pecora, FACP, as Chairman of the Board. Dr. Pecora had served as a member of the Company’s Board of Directors since January 2007.

 

John M. Gill, President and Chief Executive Officer of TetraLogic Pharmaceuticals, stated, “Drawing on his vast experience in hematology-oncology, cancer research and the business of healthcare, Dr. Pecora has contributed greatly as a member of the Board since his appointment last year. He has become actively involved in our IAP antagonist program and working with me on our company strategy. We look forward to continuing to work closely with Dr. Pecora.”